There are many stocks with exceptional dividends to check out. Here are three dividend stocks to double up on right now.

We recently compiled a list of the Top 10 Stocks to Buy According to Lee Munder Capital Group. In this article, we are going ...

Despite the death of its golden goose, AbbVie expects to achieve high single-digit compound annual sales growth to the end of ...

February is the shortest month, but that doesn't mean income investors don't have much time to find great stocks. Three ...

Global oncology portfolio sales were $1.7 billion, up 12%. Imbruvica sales were $848 million, down 6%. Venclexta sales were $655 million, up 11%. Elahere revenues were $148 million.

Any concerns about the loss of U.S. exclusivity for AbbVie's former top-selling drug Humira should be fully alleviated by now. Humira's two successors, Skyrizi and Rinvoq, combined to generate ...

Invest in essential sectors like consumer staples and energy to beat inflation. See why these stocks offer reliable dividends ...

Business is booming for Humira's two successors, Skyrizi and Rinvoq. The two drugs generated combined sales in 2024 that eclipsed Humira's peak annual sales. AbbVie projects they'll generate sales ...